Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiple cutaneous angiosarcomas after breast conserving surgery and bilateral adjuvant radiotherapy: an unusual case and review of the literature.
Meattini I, Santi R, Scartoni D, Giacomelli I, De Luca Cardillo C, Scotti V, Casella D, Simoncini R, Orzalesi L, Nori J, Paglierani M, Livi L. Meattini I, et al. Among authors: de luca cardillo c. Case Rep Oncol Med. 2014;2014:413030. doi: 10.1155/2014/413030. Epub 2014 Mar 5. Case Rep Oncol Med. 2014. PMID: 24744928 Free PMC article.
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial.
Livi L, Meattini I, Marrazzo L, Simontacchi G, Pallotta S, Saieva C, Paiar F, Scotti V, De Luca Cardillo C, Bastiani P, Orzalesi L, Casella D, Sanchez L, Nori J, Fambrini M, Bianchi S. Livi L, et al. Among authors: de luca cardillo c. Eur J Cancer. 2015 Mar;51(4):451-463. doi: 10.1016/j.ejca.2014.12.013. Epub 2015 Jan 17. Eur J Cancer. 2015. PMID: 25605582 Clinical Trial.
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial.
Meattini I, Saieva C, Marrazzo L, Di Brina L, Pallotta S, Mangoni M, Meacci F, Bendinelli B, Francolini G, Desideri I, De Luca Cardillo C, Scotti V, Furfaro IF, Rossi F, Greto D, Bonomo P, Casella D, Bernini M, Sanchez L, Orzalesi L, Simoncini R, Nori J, Bianchi S, Livi L. Meattini I, et al. Among authors: de luca cardillo c. Breast Cancer Res Treat. 2015 Oct;153(3):539-47. doi: 10.1007/s10549-015-3565-2. Epub 2015 Sep 9. Breast Cancer Res Treat. 2015. PMID: 26350524 Clinical Trial.
Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin.
Meattini I, Saieva C, Meacci F, Scotti V, De Luca Cardillo C, Desideri I, Baldazzi V, Mangoni M, Scoccianti S, Detti B, Simontacchi G, Nori J, Orzalesi L, Sanchez L, Casella D, Bernini M, Fambrini M, Bianchi S, Livi L. Meattini I, et al. Among authors: de luca cardillo c. Future Oncol. 2016 Mar;12(5):625-35. doi: 10.2217/fon.15.357. Epub 2016 Feb 3. Future Oncol. 2016. PMID: 26837239
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience.
Meattini I, Desideri I, Di Cataldo V, Francolini G, De Luca Cardillo C, Scotti V, Loi M, Detti B, Mangoni M, Agresti B, Baldazzi V, Greto D, Casella D, Bernini M, Sanchez LJ, Orzalesi L, Nori J, Fambrini M, Bianchi S, Livi L. Meattini I, et al. Among authors: de luca cardillo c. Future Oncol. 2016 May;12(9):1117-24. doi: 10.2217/fon-2015-0059. Epub 2016 Mar 9. Future Oncol. 2016. PMID: 26956105
Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: Long-term experience from two large-institutional series.
Meattini I, Saieva C, Bastiani P, Martella F, Francolini G, Lo Russo M, Paoletti L, Doria M, Desideri I, Terziani F, De Luca Cardillo C, Bendinelli B, Ciabatti C, Muntoni C, Tinacci G, Nori J, Smith H, Brancato B, Galli L, Sanchez LJ, Casella D, Bernini M, Orzalesi L, Carta GA, Bianchi S, Rossi F, Livi L. Meattini I, et al. Among authors: de luca cardillo c. Breast. 2017 Jun;33:139-144. doi: 10.1016/j.breast.2017.03.017. Epub 2017 Apr 4. Breast. 2017. PMID: 28384565
Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer.
Meattini I, Francolini G, Scotti V, De Luca Cardillo C, Cappelli S, Meacci F, Furfaro IF, Muntoni C, Scoccianti S, Detti B, Mangoni M, Nori J, Orzalesi L, Fambrini M, Bianchi S, Livi L. Meattini I, et al. Among authors: de luca cardillo c. Med Oncol. 2015 Mar;32(3):80. doi: 10.1007/s12032-015-0535-9. Epub 2015 Feb 20. Med Oncol. 2015. PMID: 25698536 Clinical Trial.
26 results